The estimated Net Worth of Osagie O Imasogie is at least $935 Thousand dollars as of 11 August 2021. Mr. Imasogie owns over 39,825 units of FS KKR Capital Corp stock worth over $935,334 and over the last 5 years he sold FSK stock worth over $0. In addition, he makes $0 as Independent Director at FS KKR Capital Corp.
Sign up
Mr. Imasogie FSK stock SEC Form 4 insiders trading
Osagie has made over 3 trades of the FS KKR Capital Corp stock since 2019, according to the Form 4 filled with the SEC. Most recently he bought 39,825 units of FSK stock worth $905,621 on 11 August 2021.
The largest trade he's ever made was buying 39,825 units of FS KKR Capital Corp stock on 11 August 2021 worth over $905,621. On average, Osagie trades about 24,828 units every 210 days since 2019. As of 11 August 2021 he still owns at least 48,488 units of FS KKR Capital Corp stock.
You can see the complete history of Mr. Imasogie stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Osagie Imasogie biography
Osagie O. Imasogie serves as Independent Director of the Company. He has over 30 years of experience in the field of law, finance, business management, healthcare and the pharmaceutical industry. He is a co-founder and the Senior Managing Partner of PIPV Capital, a Private Equity Firm that is focused on the Life Sciences vertical. Prior to co-founding PIPV Capital, Osagie conceptualized and established GlaxoSmithKline Ventures and was its founding Vice President. Mr. Imasogie has held senior commercial and R&D positions within pharmaceutical companies such as GSK, SmithKline, DuPont Merck and Endo, where he was the founding General Counsel and SVP for Corporate Development. Osagie has also been a Price Waterhouse Corporate Finance Partner as well as a practicing attorney with a leading US law firm. Mr. Imasogie is a serial entrepreneur and investor. He serves as Chairman and Founder of iLera Healthcare and was also the Founder and Chairman of Iroko Pharmaceuticals, Ception Therapeutics Inc. and Trigenesis Therapeutics Inc. In addition, he serves on the Board of a number of financial institutions such as Haverford Trust and StoneRidge Investment. Mr. Imasogie is a Trustee of the University of Pennsylvania and also a member of the Board of Overseers of the University of Pennsylvania Law School, where he is an Adjunct Professor of Law. Osagie also serves on the Board of the Philadelphia Orchestra and the Philadelphia Museum of Art. Osagie holds post-graduate degrees from the University of Pennsylvania Law School and the London School of Economics.
How old is Osagie Imasogie?
Osagie Imasogie is 58, he's been the Independent Director of FS KKR Capital Corp since 2019. There are 5 older and 21 younger executives at FS KKR Capital Corp. The oldest executive at FS KKR Capital Corp is James Kropp, 71, who is the Independent Director.
What's Osagie Imasogie's mailing address?
Osagie's mailing address filed with the SEC is C/O FS KKR CAPITAL CORP., 201 ROUSE BOULEVARD, PHILADELPHIA, PA, 19112.
Insiders trading at FS KKR Capital Corp
Over the last 5 years, insiders at FS KKR Capital Corp have traded over $6,345,044 worth of FS KKR Capital Corp stock and bought 522,074 units worth $5,553,753 . The most active insiders traders include Michael C. Forman, Daniel Pietrzak, and Brian Gerson. On average, FS KKR Capital Corp executives and independent directors trade stock every 20 days with the average trade being worth of $287,575. The most recent stock trade was executed by Michael C. Forman on 15 August 2024, trading 195,139 units of FSK stock currently worth $3,816,919.
What does FS KKR Capital Corp do?
sam investment corp is a financial services company located in 4550 w oakey blvd 104a, las vegas, nevada, united states.
What does FS KKR Capital Corp's logo look like?
Complete history of Mr. Imasogie stock trades at FS KKR Capital Corp
FS KKR Capital Corp executives and stock owners
FS KKR Capital Corp executives and other stock owners filed with the SEC include:
-
Michael Craig Forman J.D.,
Chairman & CEO -
Elizabeth Sandler,
Independent Director -
James Kropp,
Independent Director -
Osagie Imasogie,
Independent Director -
Jerel Hopkins,
Independent Director -
Jeffrey Harrow,
Independent Director -
Richard Goldstein,
Independent Director -
Brian Ford,
Independent Director -
Barbara Adams,
Independent Director -
Todd Builione,
Director -
Michael Hagan,
Lead Independent Director -
Ryan Wilson,
Co-Chief Operating Officer -
Drew OToole,
Co-Chief Operating Officer -
Zach Chalfant,
Treasurer -
Stephen Sypherd,
General Counsel, Secretary -
James Volk,
Chief Compliance Officer -
William Goebel,
Chief Accounting Officer -
Steven Lilly,
Chief Financial Officer -
Brian Gerson,
Co-President -
Daniel Pietrzak,
Co-President, Chief Investment Officer -
Michael Forman,
Chairman of the Board, Chief Executive Officer -
James Francis Volk CPA,
Chief Compliance Officer -
William Balke Goebel C.F.A., CPA, CFA, CPA,
Chief Accounting Officer -
Brian Gerson,
Co-Pres -
James Francis Volk,
Chief Compliance Officer -
Stephen S. Sypherd J.D.,
Gen. Counsel & Sec. -
Marc Yaklofsky,
Sr. VP, Head of Communications & Investor Relations -
William Balke Goebel CPA, CFA, CFA, CPA,
Chief Accounting Officer -
Drew O'Toole,
Co-Chief Operating Officer -
Ryan L.G. Wilson CFA,
Co-Chief Operating Officer -
Steven C. Lilly,
Chief Financial Officer -
Daniel Ryan Pietrzak CPA, CPA,
Co-Pres & Chief Investment Officer